These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3543178)

  • 1. Corticosterone methyloxidase II activity during hemodialysis.
    Zager PG; Spalding CT; Frey HJ; Brittenham MC
    J Lab Clin Med; 1987 Feb; 109(2):178-83. PubMed ID: 3543178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
    Kater CE; Biglieri EG; Rost CR; Schambelan M; Hirai J; Chang BC; Brust N
    J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of several adrenal steroids to ACTH stimulation in essential hypertension.
    Honda M; Nowaczynski W; Guthrie GP; Messerli FH; Tolis G; Kuchel O; Genest J
    J Clin Endocrinol Metab; 1977 Feb; 44(2):264-72. PubMed ID: 190252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma 18-hydroxycorticosterone during continuous ambulatory peritoneal dialysis.
    Zager PG; Frey HJ; Gerdes BG
    J Lab Clin Med; 1983 Oct; 102(4):604-12. PubMed ID: 6311927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of plasma aldosterone during hemodialysis in patients with terminal renal failure.
    Vetter W; Záruba K; Armbruster H; Beckerhoff R; Nussberger J; Furrer J; Fontana A; Siegenthaler W
    Nephron; 1977; 18(2):114-23. PubMed ID: 857174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The regulation of plasma aldosterone in hemodialysis patients].
    Louis F; Zwahlen A; Favre H; Vallotton M
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1882-4. PubMed ID: 7006078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective hypoaldosteronism with hyperreninemia in a diabetic patient.
    Morimoto S; Kim KS; Yamamoto I; Uchida K; Takeda R; Kornel L
    J Clin Endocrinol Metab; 1979 Nov; 49(5):742-7. PubMed ID: 489714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ACTH on plasma levels of adrenal steroids in essential hypertension.
    Honda M
    Endocrinol Jpn; 1976 Jun; 23(3):195-202. PubMed ID: 186257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multisteroid analysis in children with terminal aldosterone biosynthesis defects.
    Peter M; Partsch CJ; Sippell WG
    J Clin Endocrinol Metab; 1995 May; 80(5):1622-7. PubMed ID: 7745009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zona glomerulosa function after life-long suppression in two siblings with the hypertensive virilizing form of congenital adrenal hyperplasia.
    Rodríguez Portales JA; Arteaga E; López Moreno JM; Biglieri EG
    J Clin Endocrinol Metab; 1988 Feb; 66(2):349-54. PubMed ID: 3276723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of 11beta-hydroxylase activity with plasma corticosterone, deoxycorticosterone, cortisol, and deoxycortisol: role of ACTH and angiotensin.
    Ganguly A; Meikle AW; Tyler FH; West CD
    J Clin Endocrinol Metab; 1977 Mar; 44(3):560-8. PubMed ID: 190262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of 18-hydroxycorticosterone between red blood cells and plasma.
    Zager PG; Frey HJ; Spalding CT; Wengs WJ; Brittenham MC
    J Clin Endocrinol Metab; 1986 Jan; 62(1):84-9. PubMed ID: 3940269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin, aldosterone and other mineralocorticoids in hyperkalemic patients with chronic renal failure showing mild azotemia.
    Saruta T; Nagahama S; Eguchi T; Oka M; Kanbegawa A
    Nephron; 1981; 29(3-4):128-32. PubMed ID: 7035983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of salt-wasting disorders of adrenal and renal origin.
    Rösler A
    J Clin Endocrinol Metab; 1984 Oct; 59(4):689-700. PubMed ID: 6384251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal glomerulosa function in patients with dexamethasone-suppressible hyperaldosteronism.
    Oberfield SE; Levine LS; Stoner E; Chow D; Rauh W; Greig F; Lee SM; Lightner E; Witte M; New MI
    J Clin Endocrinol Metab; 1981 Jul; 53(1):158-64. PubMed ID: 7016891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The zonal origins of the mineralocorticoid hormones in the 21-hydroxylation deficiency of congenital adrenal hyperplasia.
    Biglieri EG; Wajchenberg BL; Malerbi DA; Okada H; Leme CE; Kater CE
    J Clin Endocrinol Metab; 1981 Nov; 53(5):964-9. PubMed ID: 6270186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone synthase gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in normal male subjects.
    Kennon B; Ingram MC; Friel EC; Anderson NH; MacKenzie SM; Davies E; Shakerdi L; Wallace AM; Fraser R; Connell JM
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):174-81. PubMed ID: 15272911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of plasma aldosterone, corticosterone, 11-deoxycorticosterone, 18-hydroxydeoxycorticosterone, cortisol, and 11-deoxycortisol. Methods and applications.
    Giordano ND; Koletsky RJ; Koletsky S
    Am J Clin Pathol; 1976 Sep; 66(3):588-97. PubMed ID: 961638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of 18-hydroxycorticosterone and aldosterone in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Zager PG; Frey HJ; Gerdes BG
    Am J Kidney Dis; 1983 Nov; 3(3):213-8. PubMed ID: 6356894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-related changes in plasma adrenal steroids during treatment with spironolactone in primary aldosteronism.
    Sakamoto H; Ichikawa S; Sakamaki T; Nakamura T; Ono Z; Takayama Y; Murata K
    Am J Hypertens; 1990 Jul; 3(7):533-7. PubMed ID: 2194510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.